arrow
R

Rocío Montejano

La Paz University Hospital
H指数:26
被引数:3,527

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metformin and Weight Changes in Non-diabetic Older People With HIV (METFORAGING): A Double-Blind, Randomized, Placebo-Controlled, Pilot Trial

二甲双胍与非糖尿病HIV感染者体重变化的关系(METFORAGING):一项双盲、随机、安慰剂对照的初步试验

2026-08-060
OAAI
Metformin and epigenetic age in non-diabetic older people with HIV in Madrid (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial

二甲双胍与表观遗传年龄在马德里非糖尿病HIV老年人群中的关系(METFORAGING):一项双盲、随机、安慰剂对照的试点试验

2026-04-180
OAAI
Prognostic Value of Blood Epigenetic Biomarkers of Aging in Persons With Well-Controlled Human Immunodeficiency Virus (HIV-1) Infection

血源性表观遗传衰老标志物在人类免疫缺陷病毒(HIV-1)感染得到良好控制的人群中的预后价值

2025-10-010
OA
Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial

多替拉韦联合拉米夫定维持治疗与比克替拉韦、恩曲他滨和阿德福韦酯在人类免疫缺陷病毒感染者中的比较(PASO-DOBLE研究):一项随机、多中心、开放标签、非劣效性试验的48周结果

2025-06-070
PRE
Dolutegravir/Lamivudine for Maintenance of Virological Suppression in Persons With Historical Suspected or Confirmed Resistance to Lamivudine: Week 48 Results of a Single-Arm, Open-Label, Multicenter, Phase IIa Clinical Trial
2025-04-010
PRE
Partial Recovery of Telomere Length After Long-term Virologic Suppression in Persons With HIV-1
2024-09-231
OAAI
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO) (vol 55, 102779, 2020)
2023-03-011
OAAI
Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns
2023-02-0110
OAAI
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance
2022-11-086
OAAI
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19: A Randomized Controlled Trial
2022-09-0117
OA
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
2022-08-2015
OA
Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients
AIDS
IF3.1
2022-07-0816
OAAI
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
2021-09-0126
OAAI